Roivant Sciences Ltd. ($ROIV)
Venker Eric โ President & Immunovant CEO
Shares
7,051
Price
$27.15
Total Value
$191,434.65
Nearby Earnings
Feb 6, 2026
EPS:Est: -0.27
Revenue:Est: $6.14M
Feb 9, 2026
EPS:Est: -0.27
Revenue:Est: $6.14M
Transaction Details
| Insider | Venker Eric |
|---|---|
| Title | President & Immunovant CEO |
| Transaction Date | Feb 20, 2026 |
| Transaction Code | F Tax Withholding |
| Acquired/Disposed | Disposed |
| Security | Common Shares |
| Direct/Indirect | Direct |
| Filing Date | Feb 24, 2026 |
| Shares Purchased | 7,051 |
| Price per Share | $27.15 |
| Total Value | $191,434.65 |
| Shares Owned After | 1,647,546 |
| Derivative | No |
| Accession Number | 0001635088-26-000022 |
| Document | View SEC Filing |